
Global pharmaceutical innovator for humans and animals. Pioneering neuroscience, endocrine, oncology, and animal health solutions.
General Medicine raises $120 million in a Series B led by Andreessen Horowitz, with participation from Matrix, VXI Capital, Eli Lilly, Mercy Health through Granger Management, and BoxGroup. The startup’s online marketplace lets consumers compare care options and prices, get guidance from licensed clinicians, and access services including prescriptions, lab tests, telehealth, and in-person visits. Its catalog includes more than 2,900 products and services, and the company says it serves hundreds of thousands of customers across every state.
Oct 2026 · Fierce HealthcareNews article
CNBC's Morning Squawk surveys a weak September for the Dow and highlights Micron's data-center growth, Google's new AI model, and Eli Lilly's obesity-drug trial. The Dow is down more than 4% in September, while Micron reports an 11-fold increase in data center revenue for its fiscal fourth quarter and provides better-than-expected guidance. Alphabet begins rolling out Gemini 4 Argon to some cyber partners; Google says the model sets records in real-world software engineering and ties for first in cybersecurity.
Oct 2026 · CNBC TechNews article
CNBC's Morning Squawk highlights rising Treasury yields, Novo's struggle to reassure investors, Meta's consumer-AI push and increased spending on cat products. The 30-year Treasury yield reaches its highest level since 2004, while mortgage rates jump to 7.45%. Novo shares fall more than 10% for the week as Eli Lilly gains ground in oral obesity drugs, while Meta rises nearly 17% after unveiling its Muse Charm device; cat spending benefits Chewy, General Mills and Petco.
Sep 2026 · CNBC TechNews article
GitHubRepository owner